CRISPR Therapeutics AG 10-K for FY2019
CRISPR Therapeutics AG (CRSP)
10-K
2020-02-12
For: 2019-12-31
View Original
Added on
April 09, 2026
About this 10-K
CRISPR Therapeutics AG filed this 10-K on February 12, 2020, covering the fiscal year ended December 31, 2019 (FY2019).
Headline figures
Fiscal year ended December 31, 2019, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $289.59M
- up 9169.8% from $3.12M a year earlier
- Net income
- $66.86M
- compared with a net loss of $164.98M a year earlier
- Diluted EPS
- $1.17
- compared with -$3.44 a year earlier